港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

羅欣藥業

16.960

-0.020-0.12%

成交量：72.00萬

成交額：1,220.91萬

市值：103.39億

市盈率：24.10

高：16.980

開：16.940

低：16.940

收：16.980

52周最高：16.980

52周最低：10.000

股本：6.10億

香港流通股本：1.65億

量比：- -

換手率：0.44%

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

市銷率: - -

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

羅欣藥業：截止至2026年1月30日，公司股東總户數為37,496

羅欣藥業2025年業績預告釋放了哪些信號？

羅欣藥業低價「甩賣」子公司引爭議，「止血」背後藏匿多重風險

股市必讀：羅欣藥業(002793)股東户數3.83萬户，較上期減少0.94%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/08058"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"08058","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"08058\",,,,,undefined,":{"symbol":"08058","market":"HK","secType":"STK","nameCN":"羅欣藥業","latestPrice":16.96,"timestamp":1496649585126,"preClose":16.98,"halted":4,"volume":720000,"delay":0,"changeRate":-0.001177856301531188,"floatShares":164560000,"shares":609600000,"eps":0.7037632952946694,"marketStatus":"退市","change":-0.02,"latestTime":"02-10 13:30:42","open":16.94,"high":16.98,"low":16.94,"amount":12209120,"amplitude":0.002356,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1770711000000},"marketStatusCode":2,"adr":0,"exchange":"SEHK","adjPreClose":16.98,"openAndCloseTimeList":[[1770687000000,1770696000000],[1770699600000,1770710400000]],"volumeRatio":0,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"08058\",,,,,undefined,":{"symbol":"08058","floatShares":164560000,"roa":"--","roe":"--","lyrEps":0,"shares":609600000,"dividePrice":0,"high":16.98,"amplitude":0.002356,"preClose":16.98,"low":16.94,"week52Low":10,"pbRate":"--","week52High":16.98,"institutionHeld":0,"latestPrice":16.96,"eps":0.7037632952946694,"divideRate":0,"volume":720000,"delay":0,"ttmEps":0,"open":16.94},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/08058\",params:#limit:5,,,undefined,":[{"date":"2017-06-16","symbol":"08058","reason":"有条件要约","type":"delisting","dateTimestamp":1497542400000},{"market":"HK","date":"2017-05-12","symbol":"08058","name":"罗欣药业","time":"","type":"earning","dateTimestamp":1494518400000,"reportTimeType":""}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"08058\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"08058\",market:\"HK\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"08058\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608859755","title":"羅欣藥業：截止至2026年1月30日，公司股東總户數為37,496","url":"https://stock-news.laohu8.com/highlight/detail?id=2608859755","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608859755?lang=zh_tw&edition=fundamental","pubTime":"2026-02-02 16:33","pubTimestamp":1770021190,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)02月02日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止1月30日已收盘公司股东人数是多少？谢谢！罗欣药业回复：尊敬的投资者，您好！截止至2026年1月30日，公司股东总户数为37,496。感谢您的关注！为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260202/31992440.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","BK0201","08058","BK0132","BK0001","002793"],"gpt_icon":0},{"id":"2607109049","title":"羅欣藥業2025年業績預告釋放了哪些信號？","url":"https://stock-news.laohu8.com/highlight/detail?id=2607109049","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607109049?lang=zh_tw&edition=fundamental","pubTime":"2026-01-30 22:07","pubTimestamp":1769782025,"startTime":"0","endTime":"0","summary":"1月30日，罗欣药业发布2025年业绩预告。报告期内，公司预计2025年度归属于母公司所有者的净利润将出现亏损，区间为万元至万元。与上年同期(万元)相比，亏损额预计大幅减少万元至万元，同比减亏幅度达%至%。　　报告同时显示，罗欣药业2025年净利润大幅减亏的原因是其核心创新药产品替戈拉生片快速增长的拉动和产品结构和增长质量持续提升。　　今天我们就借机来分析一下，罗欣药业这家老牌公司，当下及未来有哪些看点？","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260130/31988133.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0132","BK0201","BK0001","08058","002793","BK0239"],"gpt_icon":0},{"id":"2603969552","title":"羅欣藥業低價「甩賣」子公司引爭議，「止血」背後藏匿多重風險","url":"https://stock-news.laohu8.com/highlight/detail?id=2603969552","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603969552?lang=zh_tw&edition=fundamental","pubTime":"2026-01-16 17:09","pubTimestamp":1768554540,"startTime":"0","endTime":"0","summary":"近日，罗欣药业（维权）一则转让控股子公司的公告引发市场关注。公司将以6250万元的价格将旗下乐康制药100%股权转让给成立仅两年、注册资本仅20万元的君康生物。而截至2025年9月30日，乐康制药净资产为7323.83万元，交易价明显低于净资产。　　这笔“低价出售”背后，不仅暴露出标的公司持续亏损、资产萎缩的经营困境，也折射出罗欣药业近年来为扭亏频频剥离资产、债务压力渐显的复杂局面。　　乐康制药并非罗欣药业近期出售的唯一资产。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-01-16/doc-inhhnzav3923248.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0001","08058","BK0201","BK0132","002793","BK0239"],"gpt_icon":0},{"id":"2603522779","title":"股市必讀：羅欣藥業(002793)股東户數3.83萬户，較上期減少0.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603522779","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603522779?lang=zh_tw&edition=fundamental","pubTime":"2026-01-13 08:00","pubTimestamp":1768262439,"startTime":"0","endTime":"0","summary":"来自股本股东变化：截至2026年1月9日，罗欣药业股东户数为3.83万户，较前期减少365户，户均持股升至2.84万股。资金流向1月12日主力资金净流出1174.94万元；游资资金净流入310.47万元；散户资金净流入864.47万元。股东户数变动近日罗欣药业披露，截至2026年1月9日公司股东户数为3.83万户，较12月31日减少365.0户，减幅为0.94%。户均持股数量由上期的2.81万股增加至2.84万股，户均持股市值为14.29万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260113/31936006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["08058","BK0132","BK0239","002793","BK0001","BK0201"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":11,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/08058\",params:#limit:6,delay:false,,,undefined,":[]}}